SCHEMBL5159890

SCHEMBL5159890

CN(C)c1ccc(CNC(=O)N(CCc2ccccc2)C(=O)CC(C)(C)CC(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 5/20 0.41
GAA P10253 3/20 0.41
HPGD P15428 2/20 0.41
POLB P06746 1/20 0.40
EPHX2 P34913 1/20 0.40
ALOX15 P16050 4/20 0.39
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
MCL1 Q07820 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5157973 0.86 ALDH1A1 (0.50) ALDH1A1KDM4EGAAHPGDALOX15
SCHEMBL5160138 0.84 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL5160351 0.83 EPHX2 (0.46) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL5158167 0.83 ALDH1A1 (0.46) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL5495810 0.74 HPGD (0.46) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL5163832 0.74 ALDH1A1 (0.41) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL29221815 0.72 KMT2A (0.61) ALDH1A1KDM4EGAAHPGDEPHX2
SCHEMBL6407898 0.72 F7 (0.55) ALDH1A1KDM4EGAAHPGDKMT2A
SCHEMBL5160873 0.70 MAPT (0.57) ALDH1A1KDM4EGAAALOX15MAPT
SCHEMBL5159894 0.69 MEN1 (0.46) ALDH1A1KDM4EGAAHPGDEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753733-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES Avanir Pharmaceuticals (US) 2007-02-21 EP claimed
WO-2005123700-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO claimed
EP-1753733-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES Avanir Pharmaceuticals (US) 2007-02-21 EP disclosed
WO-2005123700-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO disclosed